RGEN
Repligen Corporation
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+38/100
Last price
174.84
▼ 14.66 (7.74%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
189.57
Prev close
189.50
Day high
194.36
Day low
174.36
Volume
1.70M
Market cap
$9.87B
P/E (TTM)
260.99
52W range
100.99 – 198.87
Day trading desk
Gap from prior close
+0.04%
Prior close 189.50
VWAP
179.10
-2.38% from price
Relative volume
1.11×
Normal
Session range
11.47%
174.36 – 194.36
Position in range
2%
Near session low
ATR (14D)
8.87
5.08% of price
Prior day high
191.26
PDH
Prior day low
178.61
PDL
Bid / ask spread
—
Quote not published
Session volume
1.27M
Avg 1.14M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-10.13%
-12.1%
1M
+4.33%
+3.2%
3M
+27.25%
+22.7%
6M
+51.67%
+33.5%
YTD
+6.71%
-7.5%
1Y
+17.57%
+1.1%
3Y
+9.97%
-72.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on RGEN open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+4.73K
Net buying
Buy transactions
12
23.71K shares
Sell transactions
6
18.98K shares
Net transactions
+18
Buys less sells
Sell : buy shares
0.8 : 1
Mixed
Insider-held shares
2.96M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 21, 26 | LOEILLOT OLIVIER Chief Executive Officer |
CONVERSION | 5.43K | $769.35K | Direct |
| Sep 21, 26 | LOEILLOT OLIVIER Chief Executive Officer |
SELL | 5.43K | $976.68K | Direct |
| Sep 4, 26 | LOEILLOT OLIVIER Chief Executive Officer |
SELL | 3.04K | $503.51K | Direct |
| Aug 20, 26 | LOEILLOT OLIVIER Chief Executive Officer |
CONVERSION | 5.43K | $769.35K | Direct |
| Aug 20, 26 | LOEILLOT OLIVIER Chief Executive Officer |
SELL | 5.43K | $976.68K | Direct |
| Jul 16, 26 | GARLAND JASON K. Chief Financial Officer |
SELL | 530 | $79.50K | Direct |
| Jun 25, 26 | GARLAND JASON K. Chief Financial Officer |
SELL | 733 | $106.28K | Direct |
| May 14, 26 | MHATRE ROHIN Director |
STOCK | 995 | $0 | Direct |
| May 14, 26 | KONSTANTINOV KONSTANTIN B Director |
STOCK | 995 | $0 | Direct |
| May 14, 26 | PAX MARGARET Director |
STOCK | 995 | $0 | Direct |
| May 14, 26 | DAWES KAREN A Director |
STOCK | 995 | $0 | Direct |
| May 14, 26 | BARTHELEMY NICOLAS M Director |
STOCK | 995 | $0 | Direct |
| May 14, 26 | MADAUS MARTIN D PH.D. Director |
STOCK | 995 | $0 | Direct |
| May 14, 26 | EGLINTON MANNER CARRIE Director |
STOCK | 995 | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BYLUND JAMES |
Chief Operating Officer | 25.42K | Stock Award(Grant) |
DAWES KAREN A |
Director | 92.82K | Stock Award(Grant) |
DOUGLASS BRIAN ROBB |
Officer | 8.54K | Stock Award(Grant) |
GARLAND JASON K. |
Chief Financial Officer | 18.83K | Sale |
HUGHES VIOLETTA |
Officer | 6.33K | Stock Award(Grant) |
HUNT ANTHONY JOHN |
Director | 83.69K | Conversion of Exercise of derivative security |
KURIYEL RALF |
Officer | 20.06K | Stock Award(Grant) |
LOEILLOT OLIVIER |
Chief Executive Officer | 48.37K | Conversion of Exercise of derivative security |
MADAUS MARTIN D PH.D. |
Director | 8.39K | Stock Award(Grant) |
MUIR GLENN P |
Director | 40.05K | Stock Award(Grant) |
Fundamentals
Market cap$9.87B
Enterprise value$9.75B
Revenue (TTM)$785.10M
Gross profit$422.67M
EBITDA$144.10M
Net income$41.54M
EPS (TTM)$0.67
Free cash flow$113.42M
Total cash$810.45M
Total debt$690.94M
Book value / share$37.43
Shares outstanding56.44M
Float53.47M
Short % of float11.93%
Dividend yield0.00%
Beta (5Y)1.08
Valuation & profitability ratios
Trailing P/E260.99
Forward P/E66.00
PEG ratio1.89
Price / sales—
Price / book4.67
EV / revenue12.42
EV / EBITDA67.65
Gross margin53.84%
Operating margin9.31%
Profit margin5.29%
Return on equity1.99%
Return on assets1.40%
Debt / equity32.72
Current ratio9.05
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $738.26M | $634.44M | $632.36M | $801.54M | +16.4% |
| Operating revenue | $738.26M | $634.44M | $632.36M | $801.54M | +16.4% |
| Cost of revenue | $352.01M | $359.79M | $353.92M | $345.83M | -2.2% |
| Gross profit | $386.25M | $274.64M | $278.44M | $455.71M | +40.6% |
| Research & development | $54.18M | $43.20M | $42.72M | $43.94M | +25.4% |
| Selling, general & admin | $290.51M | $263.37M | $218.58M | $215.83M | +10.3% |
| Total operating expense | $344.69M | $306.57M | $261.31M | $259.76M | +12.4% |
| Operating income | $41.56M | -$31.92M | $17.13M | $195.94M | +230.2% |
| Net interest income | -$23.17M | -$22.57M | -$10.58M | -$2.98M | -2.7% |
| Pre-tax income | $62.38M | -$27.04M | $56.71M | $219.14M | +330.7% |
| Tax provision | $13.49M | -$1.52M | $21.11M | $33.18M | +986.9% |
| Net income | $48.89M | -$25.51M | $35.60M | $185.96M | +291.6% |
| Net income to common | $48.89M | -$25.51M | $35.60M | $185.96M | +291.6% |
| Basic EPS | 0.87 | -0.46 | 0.75 | 3.35 | +289.1% |
| Diluted EPS | 0.86 | -0.46 | 0.74 | 3.24 | +287.0% |
| EBIT | $83.90M | -$6.30M | $59.21M | $220.30M | +1,430.8% |
| EBITDA | $180.85M | $80.26M | $145.32M | $277.31M | +125.3% |
| Basic shares | 56.23M | 55.94M | 55.72M | 55.46M | +0.5% |
| Diluted shares | 56.56M | 55.94M | 56.38M | 57.46M | +1.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $566.02M | $757.36M | $751.32M | $523.46M | — | -25.3% |
| Cash & short-term investments | $767.63M | $757.36M | $751.32M | $623.76M | — | +1.4% |
| Accounts receivable | $158.59M | $134.12M | $124.16M | $116.25M | — | +18.2% |
| Inventory | $170.46M | $142.96M | $202.32M | $238.28M | — | +19.2% |
| Total current assets | $1.14B | $1.07B | $1.11B | $998.12M | — | +6.7% |
| Property, plant & equipment | $306.15M | $333.12M | $322.95M | $315.70M | — | -8.1% |
| Goodwill & intangibles | $1.50B | $1.43B | $1.39B | $1.22B | — | +5.0% |
| Total assets | $2.95B | $2.83B | $2.83B | $2.53B | — | +4.2% |
| Total current liabilities | $135.83M | $126.79M | $164.94M | $404.20M | — | +7.1% |
| Current debt | — | — | $69.45M | $284.62M | $255.26M | — |
| Long-term debt | $542.21M | $525.57M | $510.14M | — | — | +3.2% |
| Total debt | $689.95M | $686.25M | $711.80M | $422.96M | — | +0.5% |
| Total liabilities | $843.57M | $856.95M | $866.34M | $620.90M | — | -1.6% |
| Retained earnings | $456.25M | $407.35M | $432.87M | $397.27M | — | +12.0% |
| Shareholder equity | $2.11B | $1.97B | $1.96B | $1.91B | — | +6.8% |
| Working capital | $1.00B | $939.25M | $946.40M | $593.92M | — | +6.6% |
| Net tangible assets | $605.57M | $543.83M | $570.77M | $694.57M | — | +11.4% |
| Shares issued | 56.33M | 56.09M | 55.77M | 55.56M | — | +0.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $48.89M | -$25.51M | $35.60M | $185.96M | +291.6% |
| Depreciation & amortisation | $96.96M | $86.56M | $86.11M | $57.01M | +12.0% |
| Stock-based compensation | $32.60M | $48.07M | $25.57M | $27.32M | -32.2% |
| Change in working capital | -$50.88M | $60.92M | -$20.09M | -$69.84M | -183.5% |
| Operating cash flow | $117.42M | $175.39M | $113.92M | $172.08M | -33.1% |
| Capital expenditure | -$25.73M | -$32.91M | -$38.99M | -$133.35M | +21.8% |
| Investing cash flow | -$298.47M | -$86.38M | -$123.28M | -$233.24M | -245.5% |
| Share buybacks | $0 | $0 | -$14.39M | $0 | — |
| Financing cash flow | -$15.21M | -$82.90M | $248.96M | -$13.34M | +81.7% |
| Free cash flow | $91.69M | $142.49M | $74.93M | $38.74M | -35.7% |
| End cash position | $566.02M | $757.36M | $751.32M | $523.46M | -25.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $204.13M | $194.25M | $197.91M | $188.81M | $182.37M | +5.1% |
| Operating revenue | $204.13M | $194.25M | $197.91M | $188.81M | $182.37M | +5.1% |
| Cost of revenue | $94.09M | $85.97M | $94.08M | $88.29M | $89.37M | +9.4% |
| Gross profit | $110.04M | $108.28M | $103.83M | $100.52M | $93.00M | +1.6% |
| Research & development | $14.42M | $14.46M | $13.12M | $14.18M | $13.97M | -0.3% |
| Selling, general & admin | $76.62M | $76.54M | $74.36M | $73.66M | $70.91M | +0.1% |
| Total operating expense | $91.03M | $90.99M | $87.48M | $87.84M | $84.88M | +0.0% |
| Operating income | $19.00M | $17.29M | $16.35M | $12.68M | $8.12M | +9.9% |
| Net interest income | -$6.08M | -$6.00M | -$5.91M | -$5.83M | -$5.77M | -1.5% |
| Pre-tax income | $14.15M | $1.77M | $19.11M | $17.11M | $18.21M | +698.7% |
| Tax provision | $9.14M | -$6.56M | $5.83M | $2.20M | $3.35M | +239.4% |
| Net income | $5.01M | $8.33M | $13.29M | $14.91M | $14.87M | -39.9% |
| Net income to common | $5.01M | $8.33M | $13.29M | $14.91M | $14.87M | -39.9% |
| Basic EPS | 0.09 | 0.15 | 0.24 | 0.27 | 0.26 | -40.0% |
| Diluted EPS | 0.09 | 0.15 | 0.23 | 0.26 | 0.26 | -40.0% |
| EBIT | $19.82M | $7.35M | $24.61M | $22.53M | $23.57M | +169.6% |
| EBITDA | $43.59M | $31.89M | $49.20M | $46.94M | $48.34M | +36.7% |
| Basic shares | 56.42M | 56.35M | 56.31M | 56.27M | 56.23M | +0.1% |
| Diluted shares | 56.64M | 56.67M | 56.66M | 56.53M | 56.51M | -0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $606.78M | $582.65M | $566.02M | $748.75M | $708.86M | +4.1% |
| Cash & short-term investments | $810.45M | $784.53M | $767.63M | $748.75M | $708.86M | +3.3% |
| Accounts receivable | $157.71M | $151.55M | $158.59M | $148.97M | $156.95M | +4.1% |
| Inventory | $186.60M | $179.26M | $170.46M | $160.32M | $155.86M | +4.1% |
| Total current assets | $1.20B | $1.16B | $1.14B | $1.10B | $1.06B | +3.4% |
| Property, plant & equipment | $283.07M | $287.11M | $306.15M | $313.09M | $321.17M | -1.4% |
| Goodwill & intangibles | $1.46B | $1.48B | $1.50B | $1.51B | $1.52B | -0.9% |
| Total assets | $2.95B | $2.93B | $2.95B | $2.92B | $2.90B | +0.7% |
| Total current liabilities | $132.66M | $126.21M | $135.83M | $131.14M | $123.01M | +5.1% |
| Long-term debt | $551.05M | $546.59M | $542.21M | $537.93M | $533.73M | +0.8% |
| Total debt | $690.94M | $687.62M | $689.95M | $688.87M | $686.06M | +0.5% |
| Total liabilities | $838.15M | $825.31M | $843.57M | $840.62M | $839.89M | +1.6% |
| Retained earnings | $469.59M | $464.58M | $456.25M | $442.96M | $428.05M | +1.1% |
| Shareholder equity | $2.11B | $2.11B | $2.11B | $2.08B | $2.06B | +0.3% |
| Working capital | $1.07B | $1.04B | $1.00B | $965.35M | $933.85M | +3.2% |
| Net tangible assets | $650.23M | $630.40M | $605.57M | $574.91M | $541.52M | +3.1% |
| Shares issued | 56.43M | 56.40M | 56.33M | 56.28M | 56.25M | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $5.01M | $8.33M | $13.29M | $14.91M | $14.87M | -39.9% |
| Depreciation & amortisation | $23.77M | $24.54M | $24.59M | $24.41M | $24.77M | -3.1% |
| Stock-based compensation | $8.01M | $8.32M | $7.98M | $8.97M | $8.38M | -3.7% |
| Change in working capital | -$12.97M | -$21.90M | -$24.35M | $12.00M | -$12.14M | +40.7% |
| Operating cash flow | $32.77M | $28.30M | $25.70M | $48.10M | $28.61M | +15.8% |
| Capital expenditure | -$6.07M | -$4.95M | -$8.31M | -$5.39M | -$7.61M | -22.7% |
| Investing cash flow | -$2.09M | -$3.99M | -$208.74M | -$7.78M | -$7.84M | +47.6% |
| Financing cash flow | -$6.20M | -$5.54M | $195.00K | -$239.00K | -$10.13M | -11.9% |
| Free cash flow | $26.70M | $23.35M | $17.39M | $42.71M | $21.00M | +14.3% |
| End cash position | $608.81M | $584.64M | $566.02M | $748.75M | $708.86M | +4.1% |
Options analytics
Put / call volume
4.41
Put-heavy session
Put / call open interest
0.63
Positioning, not flow
Max pain
185.00
+5.8% from spot
ATM implied vol
65.6%
Nearest strike to spot
Skew (10% OTM)
+10.8%
Puts bid over calls
Call volume
283
Contracts, this expiry
Put volume
1.25K
Contracts, this expiry
Heaviest call OI
200.00
2.33K contracts
Heaviest put OI
110.00
600 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.45 | 0.54 | +20.4% |
| Mar 2026 | 0.39 | 0.48 | +22.9% |
| Dec 2025 | 0.44 | 0.49 | +10.4% |
| Sep 2025 | 0.42 | 0.46 | +10.6% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.46 | 17 | $206.73M | +9.5% |
| Next quarter | 0.58 | 16 | $222.08M | +12.2% |
| Current year | 2.06 | 20 | $827.00M | +12.0% |
| Next year | 2.65 | 20 | $976.09M | +18.0% |
Analyst targets & ownership
Mean target$194.95
High target$225.00
Low target$145.00
Implied upside11.50%
Analyst count20
ConsensusSTRONG BUY
Strong buy / Buy3 / 15
Hold4
Sell / Strong sell0 / 0
Held by insiders5.24%
Held by institutions119.48%
Institutions holding659
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
186.90
-6.45% from price
SMA 20
180.11
-2.91% from price
SMA 50
171.69
+1.85% from price
SMA 100
151.16
+15.66% from price
SMA 200
143.75
+21.64% from price
EMA 12
183.35
-4.64% from price
EMA 26
179.38
-2.53% from price
EMA 50
171.24
+2.10% from price
RSI (14)
46.8
Neutral
MACD (12,26,9)
3.98
Hist -1.16
ATR (14)
8.87
5.08% of price
Realised vol 30D
49.2%
Annualised
Bollinger upper
199.47
20, 2σ
Bollinger lower
160.75
20, 2σ
50 / 200 cross
Golden
171.69 vs 143.75
Trend bias
Above 200
+21.64%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.14
More volatile than market
Correlation to SPY
0.32
Loosely linked
Realised vol 30D
49.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-40.3%
Peak to trough
Max drawdown 5Y
-66.2%
Peak to trough
ATR 14
8.87
5.08% of price
Beta (reported)
1.08
5Y monthly, from filing
Short interest
Shares short
6.71M
Prior 6.09M
Change vs prior
+10.3%
Shorts adding
% of float
11.93%
Elevated
% of shares out
11.89%
Against total outstanding
Days to cover
6.8
Crowded exit
Float
53.47M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 9, 26 | UBS | MAINTAINED | Buy | Buy |
| Jul 30, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Jul 29, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jul 7, 26 | Benchmark | UPGRADE | Hold | Buy |
| Jul 6, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Jun 3, 26 | HSBC | MAINTAINED | Buy | Buy |
| May 6, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| May 6, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Apr 20, 26 | Canaccord Genuity | MAINTAINED | Hold | Hold |
| Apr 17, 26 | Roth Capital | INITIATED | — | Buy |
| Apr 14, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Apr 6, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-10-06
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-09-30
Corporate Changes & Voting Matters
8-K · 2026-09-15
Corporate Changes & Voting Matters
8-K · 2026-09-08
Offering Registrations
S-4 · 2026-08-25
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-08-04
Periodic Financial Reports
10-Q · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-07-28
Headlines
Why Are Freshworks (FRSH) Shares Soaring Today
StockStory · 7h ago
Repligen Insider Sold Shares Worth $1,036,654, According to a Recent SEC Filing
MT Newswires · 8h ago
Repligen Closes BioLife Solutions Acquisition
MT Newswires · 13h ago
Repligen Completes Acquisition of BioLife Solutions
GlobeNewswire · 15h ago
Freshworks Set to Join S&P SmallCap 600
PR Newswire · 1d ago
Freshworks stock climbs on S&P SmallCap 600 inclusion
Investing.com · 1d ago
BioLife Solutions Shareholders Approve Repligen Merger Agreement
MarketBeat · 1d ago
3 Healthcare Stocks That Concern Us
StockStory · 5d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.